Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Plowman

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Physical Chemistry Chemical Physics : PCCP|July 2, 2013
Probing the effect of charge transfer enhancement in off resonance mode SERS via conjugation of the probe dye between silver nanoparticles and metal substratesPr Selvakannan, Rajesh Ramanathan, Blake J Plowman, et al.
Molecular Cancer Research : MCR|October 1, 2003
K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomasRoberta M James, Mark J Arends, Sarah J Plowman, et al.
Cancer Research|February 1, 1987
Preclinical antitumor activity and pharmacological properties of deoxyspergualinJ Plowman, S D Harrison, M W Trader, et al.
Investigational New Drugs|January 1, 1987
Merbarone: an antitumor agent entering clinical trialsA Glover, H G Chun, L M Kleinman, et al.
The EMBO Journal|February 15, 2008
A novel switch region regulates H-ras membrane orientation and signal outputDaniel Abankwa, Michael Hanzal-Bayer, Nicolas Ariotti, et al.
Investigational New Drugs|September 1, 1988
Preclinical antitumor activity of batracylin (NSC 320846)J Plowman, K D Paull, G Atassi, et al.
Cancer Research|April 15, 1989
Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumorsJ Plowman, S D Harrison, D J Dykes, et al.
Investigational New Drugs|January 1, 1985
Echinomycin: the first bifunctional intercalating agent in clinical trialsB J Foster, K Clagett-Carr, D D Shoemaker, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 22, 2006
K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancerS J Plowman, R L Berry, S A Bader, et al.
Molecular and Cellular Biology|June 3, 2010
Epidermal growth factor receptor activation remodels the plasma membrane lipid environment to induce nanocluster formationNicholas Ariotti, Hong Liang, Yufei Xu, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Physical Chemistry Chemical Physics : PCCP|July 2, 2013
Probing the effect of charge transfer enhancement in off resonance mode SERS via conjugation of the probe dye between silver nanoparticles and metal substratesPr Selvakannan, Rajesh Ramanathan, Blake J Plowman, et al.
Molecular Cancer Research : MCR|October 1, 2003
K-ras proto-oncogene exhibits tumor suppressor activity as its absence promotes tumorigenesis in murine teratomasRoberta M James, Mark J Arends, Sarah J Plowman, et al.
Cancer Research|February 1, 1987
Preclinical antitumor activity and pharmacological properties of deoxyspergualinJ Plowman, S D Harrison, M W Trader, et al.
Investigational New Drugs|January 1, 1987
Merbarone: an antitumor agent entering clinical trialsA Glover, H G Chun, L M Kleinman, et al.
The EMBO Journal|February 15, 2008
A novel switch region regulates H-ras membrane orientation and signal outputDaniel Abankwa, Michael Hanzal-Bayer, Nicolas Ariotti, et al.
Investigational New Drugs|September 1, 1988
Preclinical antitumor activity of batracylin (NSC 320846)J Plowman, K D Paull, G Atassi, et al.
Cancer Research|April 15, 1989
Preclinical antitumor activity of an alpha-picoline derivative, penclomedine (NSC 338720), on human and murine tumorsJ Plowman, S D Harrison, D J Dykes, et al.
Investigational New Drugs|January 1, 1985
Echinomycin: the first bifunctional intercalating agent in clinical trialsB J Foster, K Clagett-Carr, D D Shoemaker, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 22, 2006
K-ras 4A and 4B are co-expressed widely in human tissues, and their ratio is altered in sporadic colorectal cancerS J Plowman, R L Berry, S A Bader, et al.
Molecular and Cellular Biology|June 3, 2010
Epidermal growth factor receptor activation remodels the plasma membrane lipid environment to induce nanocluster formationNicholas Ariotti, Hong Liang, Yufei Xu, et al.
Pageof 11